Institutional members access full text with Ovid®

Share this article on:

New Atypical Antipsychotic Approved

Aschenbrenner, Diane S. MS, APRN-BC

AJN The American Journal of Nursing: February 2011 - Volume 111 - Issue 2 - p 27
doi: 10.1097/01.NAJ.0000394287.09836.54
Drug Watch
  • A new atypical antipsychotic drug, lurasidone (Latuda) has been approved to treat schizophrenia in adults.
  • As with other drugs in this class, lurasidone isn't approved for older adults with dementia-related psychosis.
  • Lurasidone has the same adverse effects profile as other atypical antipsychotics, including an increased risk of death, particularly from cerebrovascular causes.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:

© 2011 Lippincott Williams & Wilkins, Inc.